Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Alberto Ocana
Based on 53 articles published since 2009
(Why 53 articles?)
||||
Expertise Level
The expertise of Alberto Ocana ranks in the
  • Top 0.15%
  • ... of 263,954 published authors worldwide on Breast Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 53 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Ocaña, Alberto   ·   Ocana, A   ·   Ocaña, A   ·   Ocana, Alberto
Work Locations
Details
Most likely:    Universidad de Castilla-La Mancha      
2018
  • Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada; Sackler Faculty of Medicine, Tel Aviv University, POB 39040, Tel Aviv 6997801, Israel. · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada. Electronic address: · Translational Research Unit, Centro Regional de Investigaciones Biomedicas Universidad de Castilla La Mancha, Albacete University Hospital, calle Francisco Javier de Moya, 02006 Albacete, Spain. · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada. Electronic address: · Pubmed 30366201
  • Translational Research Unit, Albacete University Hospital, and CIBERONC, Albacete, Spain. · Centro Regional de Investigaciones Biomédicas, Universidad de Castilla-La Mancha, Albacete, Spain. · Semmelweis University 2nd Dept. of Pediatrics, Budapest, Hungary. · MTA TTK Lendület Cancer Biomarker Research Group, Institute of Enzymology, Budapest, Hungary. · Cancer Research Center, CSIC-IBSAL and CIBERONC, Salamanca, Spain. · Pubmed 30485330
  • Translational Research Unit, Calle Francisco Javier de Moya, Albacete University Hospital, and CIBERONC, 02006, Albacete, Spain. · Centro Regional de Investigaciones Biomédicas, Universidad de Castilla La Mancha, Albacete, Spain. · Semmelweis University 2nd Dept. of Pediatrics, Budapest, Hungary. · MTA TTK Lendület Cancer Biomarker Research Group, Budapest, Hungary. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. · Cancer Research Center, CSIC-IBSAL and CIBERONC, Salamanca, Spain. · Translational Research Unit, Calle Francisco Javier de Moya, Albacete University Hospital, and CIBERONC, 02006, Albacete, Spain. · Centro Regional de Investigaciones Biomédicas, Universidad de Castilla La Mancha, Albacete, Spain. · Pubmed 30206781
  • Department of Medical Oncology, St. Claraspital, Basel, Switzerland. · Faculty of Medicine, University of Basel, Basel, Switzerland. · Hospital Universitario de Elche, Elche, Spain. · GEICAM (Spanish Breast Cancer Group), Madrid, Spain. · Instituto Valenciano de Oncología, Valencia, Spain. · Hospital Virgen de la Victoria, Málaga, Spain. · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. · Complejo Hospitalario Juan Canalejo, A Coruña, Spain. · Hospital Univ. Virgen del Rocío, Seville, Spain. · Hospital Universitario La Fe, Valencia, Spain. · Hospital Clínico Universitario de Salamanca, Salamanca (IBSAL), Salamanca, Spain. · Hospital Ramón y Cajal, Madrid, Spain. · Centro Oncológico de Galicia, A Coruña, Spain. · Hospital de Cabueñes, Gijón, Spain. · Biomedical Research Institute INCLIVA, Hospital Clínico Universitario de Valencia, University of Valencia, Valencia, Spain. · Hospital de Donostia, San Sebastián, Spain. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada. · Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain. · GEICAM (Spanish Breast Cancer Group), Madrid, Spain. · Complejo Hospitalario Universitario de Albacetee, Centro Regional de Investigaciones Biomédicas, Universidad de Castilla la Mancha, Albacete, Spain. · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Edificio de Investigación, Calle Francisco Javier de Moya, 02006, Albacete, Spain. · Pubmed 29766456
2017
  • Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada; Sackler Faculty of Medicine, Tel Aviv University, POB 39040, Tel Aviv 6997801, Israel. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada. Electronic address: · Department of Medical Oncology, Institute of Oncology Ljubljana, 2 Zaloska cesta, Ljubljana 1000, Slovenia. Electronic address: · Department of Oncology and Hematology, St. Claraspital, Faculty of Medicine, University of Basel, Kleinriehenstrasse 30, Basel 4058, Switzerland. Electronic address: · Translational Research Unit, Centro Regional de Investigaciones Biomedicas Universidad de Castilla La Mancha, Albacete University Hospital, calle Francisco Javier de Moya 02006, Albacete, Spain. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada. Electronic address: · Pubmed 28881223
  • Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON, M5G 2M9, Canada; Sackler Faculty of Medicine, Tel Aviv University, POB 39040, Tel Aviv 6997801, Israel. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON, M5G 2M9, Canada. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON, M5G 2M9, Canada. Electronic address: · Department of Medical Oncology, Institute of Oncology Ljubljana, 2 Zaloska cesta, Ljubljana 1000, Slovenia. Electronic address: · Department of Oncology and Hematology, St. Claraspital, Faculty of Medicine, University of Basel, Kleinriehenstrasse 30, Basel 4058, Switzerland. Electronic address: · Translational Research Unit, Centro Regional de Investigaciones Biomedicas Universidad de Castilla La Mancha, Albacete University Hospital, calle Francisco Javier de Moya 02006, Albacete, Spain. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON, M5G 2M9, Canada. Electronic address: · Pubmed 28734183
  • Unidad de Investigación Traslacional, Hospital Universitario de Albacete, Universidad de Castilla La Mancha, Albacete, Spain. · Instituto de Biología Molecular y Celular del Cáncer and CIBERONC. CSIC-Universidad de Salamanca, Salamanca, Spain. · Pubmed 28108739
  • Instituto de Biología Molecular y Celular del Cáncer (IBMCC-CIC), CSIC, Salamanca, Spain. · Unidad de Investigación Traslacional, Hospital Universitario de Albacete, Universidad de Castilla La Mancha, Albacete, Spain. · Centro Regional de Investigaciones Biomédicas (CRIB), Universidad de Castilla La Mancha, Albacete, Spain. · CIBERONC, Madrid, Spain. · Pubmed 29032615
  • Translational Research Unit, Albacete University Hospital and CIBERONC, Albacete, Spain. · Centro Regional de Investigaciones Biomédicas (CRIB), Universidad de Castilla La Mancha, Albacete, Spain. · Princess Margaret Cancer Center, University of Toronto, Toronto, Canada. · Cancer Research Center and CIBERONC, CSIC-University of Salamanca, Salamanca, Spain. · MTA TTK Lendület Cancer Biomarker Research Group, Budapest, Hungary. · Semmelweis University 2nd Dept. of Pediatrics, Budapest, Hungary. · Pubmed 28472085
  • Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Centro Regional de Investigaciones Biomédicas (CRIB), Universidad de Castilla La Mancha, Albacete, Spain. · Cancer Research Center, CSIC-University of Salamanca, Salamanca, Spain. · Pubmed 28061448
2019
  • Department of Medical Oncology, Hospital Clínico San Carlos, Madrid and Centro Regional de Investigaciones Biomédicas, Universidad de Castilla La Mancha, 02006, Albacete, Spain. · GEICAM, Spanish Breast Cancer Group, Madrid, Spain. · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. · GEICAM, Spanish Breast Cancer Group, Madrid, Spain. · Department of Medical Oncology, Institut Català d'Oncologia (ICO)-IDIBELL, L'Hospitalet, Barcelona, Spain. · Department of Medical Oncology, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain. · Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Sevilla, Spain. · Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Institute of Biomedical Reasearch in Malaga, Malaga, Spain. · Department of Medical Oncology, Fundación Onkologikoa, Donostia, Spain. · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. · Instituto de Biología Molecular y Celular del Cáncer, IBSAL, CSIC-Universidad de Salamanca, Salamanca, Spain. · Fundación Jiménez Díaz, Madrid, Spain. · Pubmed 30607629
Probable:    Instituto de Salud Carlos III      
2018
  • Division of Medical Oncology, Princess Margaret Cancer Centre and the University of Toronto, 610 University Ave, Toronto, ON, M5G 2M9, Canada. · Sackler Faculty of Medicine, Tel Aviv University, P.O. Box 39040, 6997801, Tel Aviv, Israel. · Department of Medical Oncology, Institute of Oncology Ljubljana, 2 Zaloska cesta, 1000, Ljubljana, Slovenia. · Translational Research Unit, Albacete University Hospital and CIBERONC, calle Francisco Javier de Moya, 02006, Albacete, Spain. · Division of Medical Oncology, Princess Margaret Cancer Centre and the University of Toronto, 610 University Ave, Toronto, ON, M5G 2M9, Canada. · Pubmed 29423899
  • Translational Research Unit, Albacete University Hospital, and CIBERONC, Albacete, Spain. · Centro Regional de Investigaciones Biomédicas, Universidad de Castilla-La Mancha, Albacete, Spain. · Semmelweis University 2nd Dept. of Pediatrics, Budapest, Hungary. · MTA TTK Lendület Cancer Biomarker Research Group, Institute of Enzymology, Budapest, Hungary. · Cancer Research Center, CSIC-IBSAL and CIBERONC, Salamanca, Spain. · Pubmed 30485330
  • Translational Research Unit, Calle Francisco Javier de Moya, Albacete University Hospital, and CIBERONC, 02006, Albacete, Spain. · Centro Regional de Investigaciones Biomédicas, Universidad de Castilla La Mancha, Albacete, Spain. · Semmelweis University 2nd Dept. of Pediatrics, Budapest, Hungary. · MTA TTK Lendület Cancer Biomarker Research Group, Budapest, Hungary. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. · Cancer Research Center, CSIC-IBSAL and CIBERONC, Salamanca, Spain. · Translational Research Unit, Calle Francisco Javier de Moya, Albacete University Hospital, and CIBERONC, 02006, Albacete, Spain. · Centro Regional de Investigaciones Biomédicas, Universidad de Castilla La Mancha, Albacete, Spain. · Pubmed 30206781
  • Department of Medical Oncology, Kingston Health Sciences Centre, Queen's University, Kingston, Ontario, Canada. · Complejo Hospitalario de Albacete, Albacete, Spain; GEICAM (Spanish Breast Cancer Group), Spain; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Spain. · GEICAM (Spanish Breast Cancer Group), Spain; Hospital Universitario de Elche, Elche, Spain. · GEICAM (Spanish Breast Cancer Group), Spain; Instituto Valenciano de Oncología, Valencia, Spain. · GEICAM (Spanish Breast Cancer Group), Spain; Hospital Virgen de La Victoria, Málaga, Spain; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Spain. · GEICAM (Spanish Breast Cancer Group), Spain; Complejo Hospitalario Universitario A Coruña, A Coruña, Spain. · GEICAM (Spanish Breast Cancer Group), Spain; Hospital Univ. Virgen Del Rocío, Sevilla, Spain. · GEICAM (Spanish Breast Cancer Group), Spain; Hospital Universitario La Fe, Valencia, Spain. · GEICAM (Spanish Breast Cancer Group), Spain; Hospital Clínico Universitario de Salamanca, Salamanca (IBSAL), Spain. · GEICAM (Spanish Breast Cancer Group), Spain; Hospital Ramón y Cajal, Madrid, Spain. · GEICAM (Spanish Breast Cancer Group), Spain; Centro Oncológico de Galicia, A Coruña, Spain. · GEICAM (Spanish Breast Cancer Group), Spain; Hospital de Cabueñes, Gijón, Spain. · GEICAM (Spanish Breast Cancer Group), Spain; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Spain; Hospital Clínico Universitario de Valencia, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain. · GEICAM (Spanish Breast Cancer Group), Spain; Hospital de Donostia, San Sebastián, Spain. · GEICAM (Spanish Breast Cancer Group), Spain. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada. · GEICAM (Spanish Breast Cancer Group), Spain; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain. Electronic address: · Pubmed 29573665
2017
  • Instituto de Biología Molecular y Celular del Cáncer (IBMCC-CIC), CSIC, Salamanca, Spain. · Unidad de Investigación Traslacional, Hospital Universitario de Albacete, Universidad de Castilla La Mancha, Albacete, Spain. · Centro Regional de Investigaciones Biomédicas (CRIB), Universidad de Castilla La Mancha, Albacete, Spain. · CIBERONC, Madrid, Spain. · Pubmed 29032615
  • Translational Research Unit, Albacete University Hospital and CIBERONC, Albacete, Spain. · Centro Regional de Investigaciones Biomédicas (CRIB), Universidad de Castilla La Mancha, Albacete, Spain. · Princess Margaret Cancer Center, University of Toronto, Toronto, Canada. · Cancer Research Center and CIBERONC, CSIC-University of Salamanca, Salamanca, Spain. · MTA TTK Lendület Cancer Biomarker Research Group, Budapest, Hungary. · Semmelweis University 2nd Dept. of Pediatrics, Budapest, Hungary. · Pubmed 28472085
2019
  • Department of Medical Oncology, Hospital Clínico San Carlos, Madrid and Centro Regional de Investigaciones Biomédicas, Universidad de Castilla La Mancha, 02006, Albacete, Spain. · GEICAM, Spanish Breast Cancer Group, Madrid, Spain. · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. · GEICAM, Spanish Breast Cancer Group, Madrid, Spain. · Department of Medical Oncology, Institut Català d'Oncologia (ICO)-IDIBELL, L'Hospitalet, Barcelona, Spain. · Department of Medical Oncology, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain. · Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Sevilla, Spain. · Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Institute of Biomedical Reasearch in Malaga, Malaga, Spain. · Department of Medical Oncology, Fundación Onkologikoa, Donostia, Spain. · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. · Instituto de Biología Molecular y Celular del Cáncer, IBSAL, CSIC-Universidad de Salamanca, Salamanca, Spain. · Fundación Jiménez Díaz, Madrid, Spain. · Pubmed 30607629
Probable:    Miscellaneous institutions in Madrid      
2018
  • Department of Medical Oncology, St. Claraspital, Basel, Switzerland. · Faculty of Medicine, University of Basel, Basel, Switzerland. · Hospital Universitario de Elche, Elche, Spain. · GEICAM (Spanish Breast Cancer Group), Madrid, Spain. · Instituto Valenciano de Oncología, Valencia, Spain. · Hospital Virgen de la Victoria, Málaga, Spain. · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. · Complejo Hospitalario Juan Canalejo, A Coruña, Spain. · Hospital Univ. Virgen del Rocío, Seville, Spain. · Hospital Universitario La Fe, Valencia, Spain. · Hospital Clínico Universitario de Salamanca, Salamanca (IBSAL), Salamanca, Spain. · Hospital Ramón y Cajal, Madrid, Spain. · Centro Oncológico de Galicia, A Coruña, Spain. · Hospital de Cabueñes, Gijón, Spain. · Biomedical Research Institute INCLIVA, Hospital Clínico Universitario de Valencia, University of Valencia, Valencia, Spain. · Hospital de Donostia, San Sebastián, Spain. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada. · Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain. · GEICAM (Spanish Breast Cancer Group), Madrid, Spain. · Complejo Hospitalario Universitario de Albacetee, Centro Regional de Investigaciones Biomédicas, Universidad de Castilla la Mancha, Albacete, Spain. · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Edificio de Investigación, Calle Francisco Javier de Moya, 02006, Albacete, Spain. · Pubmed 29766456
2019
  • Department of Medical Oncology, Hospital Clínico San Carlos, Madrid and Centro Regional de Investigaciones Biomédicas, Universidad de Castilla La Mancha, 02006, Albacete, Spain. · GEICAM, Spanish Breast Cancer Group, Madrid, Spain. · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. · GEICAM, Spanish Breast Cancer Group, Madrid, Spain. · Department of Medical Oncology, Institut Català d'Oncologia (ICO)-IDIBELL, L'Hospitalet, Barcelona, Spain. · Department of Medical Oncology, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain. · Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Sevilla, Spain. · Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Institute of Biomedical Reasearch in Malaga, Malaga, Spain. · Department of Medical Oncology, Fundación Onkologikoa, Donostia, Spain. · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. · Instituto de Biología Molecular y Celular del Cáncer, IBSAL, CSIC-Universidad de Salamanca, Salamanca, Spain. · Fundación Jiménez Díaz, Madrid, Spain. · Pubmed 30607629
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 53 total) written by Alberto Ocana about Breast Neoplasms:

  • Efficacy and safety of dasatinib with trastuzumab and paclitaxel in first line HER2-positive metastatic breast cancer: results from the phase II GEICAM/2010-04 study. 2019
  • Absolute benefit from adjuvant chemotherapy in contemporary clinical trials: A systemic review and meta-analysis. 2018
  • Influence of control group therapy on the benefit from dose-dense chemotherapy in early breast cancer: a systemic review and meta-analysis. 2018
  • Epidermal growth factor receptor overexpression and outcomes in early breast cancer: A systematic review and a meta-analysis. 2018
  • Toxicity of Extended Adjuvant Therapy With Aromatase Inhibitors in Early Breast Cancer: A Systematic Review and Meta-analysis. 2018
  • Evaluation of transcriptionally regulated genes identifies NCOR1 in hormone receptor negative breast tumors and lung adenocarcinomas as a potential tumor suppressor gene. 2018
  • Epigenetic modulation of FOXM1-gene interacting network by BET inhibitors in breast cancer. 2018
  • Prognostic role for the derived neutrophil-to-lymphocyte ratio in early breast cancer: a GEICAM/9906 substudy. 2018
  • Outcomes of single versus double hormone receptor-positive breast cancer. A GEICAM/9906 sub-study. 2018
  • Functional transcriptomic annotation and protein-protein interaction network analysis identify NEK2, BIRC5, and TOP2A as potential targets in obese patients with luminal A breast cancer. 2018
Show List of Full Article Records
Google Searches

Learn more about Alberto Ocana using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Universidad de Castilla-La Mancha
Instituto de Salud Carlos III
Miscellaneous institutions in Madrid
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Universidad de Castilla-La Mancha
2018
  • Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada; Sackler Faculty of Medicine, Tel Aviv University, POB 39040, Tel Aviv 6997801, Israel. · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada. Electronic address: · Translational Research Unit, Centro Regional de Investigaciones Biomedicas Universidad de Castilla La Mancha, Albacete University Hospital, calle Francisco Javier de Moya, 02006 Albacete, Spain. · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada. Electronic address: · Pubmed 30366201
  • Translational Research Unit, Albacete University Hospital, and CIBERONC, Albacete, Spain. · Centro Regional de Investigaciones Biomédicas, Universidad de Castilla-La Mancha, Albacete, Spain. · Semmelweis University 2nd Dept. of Pediatrics, Budapest, Hungary. · MTA TTK Lendület Cancer Biomarker Research Group, Institute of Enzymology, Budapest, Hungary. · Cancer Research Center, CSIC-IBSAL and CIBERONC, Salamanca, Spain. · Pubmed 30485330
  • Translational Research Unit, Calle Francisco Javier de Moya, Albacete University Hospital, and CIBERONC, 02006, Albacete, Spain. · Centro Regional de Investigaciones Biomédicas, Universidad de Castilla La Mancha, Albacete, Spain. · Semmelweis University 2nd Dept. of Pediatrics, Budapest, Hungary. · MTA TTK Lendület Cancer Biomarker Research Group, Budapest, Hungary. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. · Cancer Research Center, CSIC-IBSAL and CIBERONC, Salamanca, Spain. · Translational Research Unit, Calle Francisco Javier de Moya, Albacete University Hospital, and CIBERONC, 02006, Albacete, Spain. · Centro Regional de Investigaciones Biomédicas, Universidad de Castilla La Mancha, Albacete, Spain. · Pubmed 30206781
  • Department of Medical Oncology, St. Claraspital, Basel, Switzerland. · Faculty of Medicine, University of Basel, Basel, Switzerland. · Hospital Universitario de Elche, Elche, Spain. · GEICAM (Spanish Breast Cancer Group), Madrid, Spain. · Instituto Valenciano de Oncología, Valencia, Spain. · Hospital Virgen de la Victoria, Málaga, Spain. · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. · Complejo Hospitalario Juan Canalejo, A Coruña, Spain. · Hospital Univ. Virgen del Rocío, Seville, Spain. · Hospital Universitario La Fe, Valencia, Spain. · Hospital Clínico Universitario de Salamanca, Salamanca (IBSAL), Salamanca, Spain. · Hospital Ramón y Cajal, Madrid, Spain. · Centro Oncológico de Galicia, A Coruña, Spain. · Hospital de Cabueñes, Gijón, Spain. · Biomedical Research Institute INCLIVA, Hospital Clínico Universitario de Valencia, University of Valencia, Valencia, Spain. · Hospital de Donostia, San Sebastián, Spain. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada. · Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain. · GEICAM (Spanish Breast Cancer Group), Madrid, Spain. · Complejo Hospitalario Universitario de Albacetee, Centro Regional de Investigaciones Biomédicas, Universidad de Castilla la Mancha, Albacete, Spain. · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Edificio de Investigación, Calle Francisco Javier de Moya, 02006, Albacete, Spain. · Pubmed 29766456
2017
  • Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada; Sackler Faculty of Medicine, Tel Aviv University, POB 39040, Tel Aviv 6997801, Israel. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada. Electronic address: · Department of Medical Oncology, Institute of Oncology Ljubljana, 2 Zaloska cesta, Ljubljana 1000, Slovenia. Electronic address: · Department of Oncology and Hematology, St. Claraspital, Faculty of Medicine, University of Basel, Kleinriehenstrasse 30, Basel 4058, Switzerland. Electronic address: · Translational Research Unit, Centro Regional de Investigaciones Biomedicas Universidad de Castilla La Mancha, Albacete University Hospital, calle Francisco Javier de Moya 02006, Albacete, Spain. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada. Electronic address: · Pubmed 28881223
  • Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON, M5G 2M9, Canada; Sackler Faculty of Medicine, Tel Aviv University, POB 39040, Tel Aviv 6997801, Israel. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON, M5G 2M9, Canada. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON, M5G 2M9, Canada. Electronic address: · Department of Medical Oncology, Institute of Oncology Ljubljana, 2 Zaloska cesta, Ljubljana 1000, Slovenia. Electronic address: · Department of Oncology and Hematology, St. Claraspital, Faculty of Medicine, University of Basel, Kleinriehenstrasse 30, Basel 4058, Switzerland. Electronic address: · Translational Research Unit, Centro Regional de Investigaciones Biomedicas Universidad de Castilla La Mancha, Albacete University Hospital, calle Francisco Javier de Moya 02006, Albacete, Spain. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON, M5G 2M9, Canada. Electronic address: · Pubmed 28734183
  • Unidad de Investigación Traslacional, Hospital Universitario de Albacete, Universidad de Castilla La Mancha, Albacete, Spain. · Instituto de Biología Molecular y Celular del Cáncer and CIBERONC. CSIC-Universidad de Salamanca, Salamanca, Spain. · Pubmed 28108739
  • Instituto de Biología Molecular y Celular del Cáncer (IBMCC-CIC), CSIC, Salamanca, Spain. · Unidad de Investigación Traslacional, Hospital Universitario de Albacete, Universidad de Castilla La Mancha, Albacete, Spain. · Centro Regional de Investigaciones Biomédicas (CRIB), Universidad de Castilla La Mancha, Albacete, Spain. · CIBERONC, Madrid, Spain. · Pubmed 29032615
  • Translational Research Unit, Albacete University Hospital and CIBERONC, Albacete, Spain. · Centro Regional de Investigaciones Biomédicas (CRIB), Universidad de Castilla La Mancha, Albacete, Spain. · Princess Margaret Cancer Center, University of Toronto, Toronto, Canada. · Cancer Research Center and CIBERONC, CSIC-University of Salamanca, Salamanca, Spain. · MTA TTK Lendület Cancer Biomarker Research Group, Budapest, Hungary. · Semmelweis University 2nd Dept. of Pediatrics, Budapest, Hungary. · Pubmed 28472085
  • Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Centro Regional de Investigaciones Biomédicas (CRIB), Universidad de Castilla La Mancha, Albacete, Spain. · Cancer Research Center, CSIC-University of Salamanca, Salamanca, Spain. · Pubmed 28061448
2019
  • Department of Medical Oncology, Hospital Clínico San Carlos, Madrid and Centro Regional de Investigaciones Biomédicas, Universidad de Castilla La Mancha, 02006, Albacete, Spain. · GEICAM, Spanish Breast Cancer Group, Madrid, Spain. · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. · GEICAM, Spanish Breast Cancer Group, Madrid, Spain. · Department of Medical Oncology, Institut Català d'Oncologia (ICO)-IDIBELL, L'Hospitalet, Barcelona, Spain. · Department of Medical Oncology, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain. · Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Sevilla, Spain. · Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Institute of Biomedical Reasearch in Malaga, Malaga, Spain. · Department of Medical Oncology, Fundación Onkologikoa, Donostia, Spain. · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. · Instituto de Biología Molecular y Celular del Cáncer, IBSAL, CSIC-Universidad de Salamanca, Salamanca, Spain. · Fundación Jiménez Díaz, Madrid, Spain. · Pubmed 30607629
Instituto de Salud Carlos III
2018
  • Division of Medical Oncology, Princess Margaret Cancer Centre and the University of Toronto, 610 University Ave, Toronto, ON, M5G 2M9, Canada. · Sackler Faculty of Medicine, Tel Aviv University, P.O. Box 39040, 6997801, Tel Aviv, Israel. · Department of Medical Oncology, Institute of Oncology Ljubljana, 2 Zaloska cesta, 1000, Ljubljana, Slovenia. · Translational Research Unit, Albacete University Hospital and CIBERONC, calle Francisco Javier de Moya, 02006, Albacete, Spain. · Division of Medical Oncology, Princess Margaret Cancer Centre and the University of Toronto, 610 University Ave, Toronto, ON, M5G 2M9, Canada. · Pubmed 29423899
  • Translational Research Unit, Albacete University Hospital, and CIBERONC, Albacete, Spain. · Centro Regional de Investigaciones Biomédicas, Universidad de Castilla-La Mancha, Albacete, Spain. · Semmelweis University 2nd Dept. of Pediatrics, Budapest, Hungary. · MTA TTK Lendület Cancer Biomarker Research Group, Institute of Enzymology, Budapest, Hungary. · Cancer Research Center, CSIC-IBSAL and CIBERONC, Salamanca, Spain. · Pubmed 30485330
  • Translational Research Unit, Calle Francisco Javier de Moya, Albacete University Hospital, and CIBERONC, 02006, Albacete, Spain. · Centro Regional de Investigaciones Biomédicas, Universidad de Castilla La Mancha, Albacete, Spain. · Semmelweis University 2nd Dept. of Pediatrics, Budapest, Hungary. · MTA TTK Lendület Cancer Biomarker Research Group, Budapest, Hungary. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. · Cancer Research Center, CSIC-IBSAL and CIBERONC, Salamanca, Spain. · Translational Research Unit, Calle Francisco Javier de Moya, Albacete University Hospital, and CIBERONC, 02006, Albacete, Spain. · Centro Regional de Investigaciones Biomédicas, Universidad de Castilla La Mancha, Albacete, Spain. · Pubmed 30206781
  • Department of Medical Oncology, Kingston Health Sciences Centre, Queen's University, Kingston, Ontario, Canada. · Complejo Hospitalario de Albacete, Albacete, Spain; GEICAM (Spanish Breast Cancer Group), Spain; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Spain. · GEICAM (Spanish Breast Cancer Group), Spain; Hospital Universitario de Elche, Elche, Spain. · GEICAM (Spanish Breast Cancer Group), Spain; Instituto Valenciano de Oncología, Valencia, Spain. · GEICAM (Spanish Breast Cancer Group), Spain; Hospital Virgen de La Victoria, Málaga, Spain; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Spain. · GEICAM (Spanish Breast Cancer Group), Spain; Complejo Hospitalario Universitario A Coruña, A Coruña, Spain. · GEICAM (Spanish Breast Cancer Group), Spain; Hospital Univ. Virgen Del Rocío, Sevilla, Spain. · GEICAM (Spanish Breast Cancer Group), Spain; Hospital Universitario La Fe, Valencia, Spain. · GEICAM (Spanish Breast Cancer Group), Spain; Hospital Clínico Universitario de Salamanca, Salamanca (IBSAL), Spain. · GEICAM (Spanish Breast Cancer Group), Spain; Hospital Ramón y Cajal, Madrid, Spain. · GEICAM (Spanish Breast Cancer Group), Spain; Centro Oncológico de Galicia, A Coruña, Spain. · GEICAM (Spanish Breast Cancer Group), Spain; Hospital de Cabueñes, Gijón, Spain. · GEICAM (Spanish Breast Cancer Group), Spain; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Spain; Hospital Clínico Universitario de Valencia, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain. · GEICAM (Spanish Breast Cancer Group), Spain; Hospital de Donostia, San Sebastián, Spain. · GEICAM (Spanish Breast Cancer Group), Spain. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada. · GEICAM (Spanish Breast Cancer Group), Spain; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain. Electronic address: · Pubmed 29573665
2017
  • Instituto de Biología Molecular y Celular del Cáncer (IBMCC-CIC), CSIC, Salamanca, Spain. · Unidad de Investigación Traslacional, Hospital Universitario de Albacete, Universidad de Castilla La Mancha, Albacete, Spain. · Centro Regional de Investigaciones Biomédicas (CRIB), Universidad de Castilla La Mancha, Albacete, Spain. · CIBERONC, Madrid, Spain. · Pubmed 29032615
  • Translational Research Unit, Albacete University Hospital and CIBERONC, Albacete, Spain. · Centro Regional de Investigaciones Biomédicas (CRIB), Universidad de Castilla La Mancha, Albacete, Spain. · Princess Margaret Cancer Center, University of Toronto, Toronto, Canada. · Cancer Research Center and CIBERONC, CSIC-University of Salamanca, Salamanca, Spain. · MTA TTK Lendület Cancer Biomarker Research Group, Budapest, Hungary. · Semmelweis University 2nd Dept. of Pediatrics, Budapest, Hungary. · Pubmed 28472085
2019
  • Department of Medical Oncology, Hospital Clínico San Carlos, Madrid and Centro Regional de Investigaciones Biomédicas, Universidad de Castilla La Mancha, 02006, Albacete, Spain. · GEICAM, Spanish Breast Cancer Group, Madrid, Spain. · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. · GEICAM, Spanish Breast Cancer Group, Madrid, Spain. · Department of Medical Oncology, Institut Català d'Oncologia (ICO)-IDIBELL, L'Hospitalet, Barcelona, Spain. · Department of Medical Oncology, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain. · Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Sevilla, Spain. · Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Institute of Biomedical Reasearch in Malaga, Malaga, Spain. · Department of Medical Oncology, Fundación Onkologikoa, Donostia, Spain. · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. · Instituto de Biología Molecular y Celular del Cáncer, IBSAL, CSIC-Universidad de Salamanca, Salamanca, Spain. · Fundación Jiménez Díaz, Madrid, Spain. · Pubmed 30607629
Miscellaneous institutions in Madrid
2018
  • Department of Medical Oncology, St. Claraspital, Basel, Switzerland. · Faculty of Medicine, University of Basel, Basel, Switzerland. · Hospital Universitario de Elche, Elche, Spain. · GEICAM (Spanish Breast Cancer Group), Madrid, Spain. · Instituto Valenciano de Oncología, Valencia, Spain. · Hospital Virgen de la Victoria, Málaga, Spain. · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. · Complejo Hospitalario Juan Canalejo, A Coruña, Spain. · Hospital Univ. Virgen del Rocío, Seville, Spain. · Hospital Universitario La Fe, Valencia, Spain. · Hospital Clínico Universitario de Salamanca, Salamanca (IBSAL), Salamanca, Spain. · Hospital Ramón y Cajal, Madrid, Spain. · Centro Oncológico de Galicia, A Coruña, Spain. · Hospital de Cabueñes, Gijón, Spain. · Biomedical Research Institute INCLIVA, Hospital Clínico Universitario de Valencia, University of Valencia, Valencia, Spain. · Hospital de Donostia, San Sebastián, Spain. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada. · Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain. · GEICAM (Spanish Breast Cancer Group), Madrid, Spain. · Complejo Hospitalario Universitario de Albacetee, Centro Regional de Investigaciones Biomédicas, Universidad de Castilla la Mancha, Albacete, Spain. · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Edificio de Investigación, Calle Francisco Javier de Moya, 02006, Albacete, Spain. · Pubmed 29766456
2019
  • Department of Medical Oncology, Hospital Clínico San Carlos, Madrid and Centro Regional de Investigaciones Biomédicas, Universidad de Castilla La Mancha, 02006, Albacete, Spain. · GEICAM, Spanish Breast Cancer Group, Madrid, Spain. · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. · GEICAM, Spanish Breast Cancer Group, Madrid, Spain. · Department of Medical Oncology, Institut Català d'Oncologia (ICO)-IDIBELL, L'Hospitalet, Barcelona, Spain. · Department of Medical Oncology, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain. · Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Sevilla, Spain. · Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Institute of Biomedical Reasearch in Malaga, Malaga, Spain. · Department of Medical Oncology, Fundación Onkologikoa, Donostia, Spain. · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. · Instituto de Biología Molecular y Celular del Cáncer, IBSAL, CSIC-Universidad de Salamanca, Salamanca, Spain. · Fundación Jiménez Díaz, Madrid, Spain. · Pubmed 30607629
Miscellaneous institutions in Albacete
2018
  • Centro Universitario Contra el Cáncer, Hospital Universitario, Universidad Autónoma de Nuevo León, Monterrey, Mexico. · Centro Universitario Contra el Cáncer, Hospital Universitario, Universidad Autónoma de Nuevo León, Monterrey, Mexico; Canadian Cancer Trials Group, Department of Medical Oncology, Faculty of Medicine, Queen's University, Kingston, Ontario, Canada. · Department of Medical Oncology, St Claraspital and Faculty of Medicine, University of Basel, Basel, Switzerland. · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada. · Centro Universitario Contra el Cáncer, Hospital Universitario, Universidad Autónoma de Nuevo León, Monterrey, Mexico; Canadian Cancer Trials Group, Department of Medical Oncology, Faculty of Medicine, Queen's University, Kingston, Ontario, Canada. Electronic address: · Pubmed 29126017
  • Department of Medical Oncology, St. Claraspital, Basel, Switzerland. · Faculty of Medicine, University of Basel, Basel, Switzerland. · Hospital Universitario de Elche, Elche, Spain. · GEICAM (Spanish Breast Cancer Group), Madrid, Spain. · Instituto Valenciano de Oncología, Valencia, Spain. · Hospital Virgen de la Victoria, Málaga, Spain. · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. · Complejo Hospitalario Juan Canalejo, A Coruña, Spain. · Hospital Univ. Virgen del Rocío, Seville, Spain. · Hospital Universitario La Fe, Valencia, Spain. · Hospital Clínico Universitario de Salamanca, Salamanca (IBSAL), Salamanca, Spain. · Hospital Ramón y Cajal, Madrid, Spain. · Centro Oncológico de Galicia, A Coruña, Spain. · Hospital de Cabueñes, Gijón, Spain. · Biomedical Research Institute INCLIVA, Hospital Clínico Universitario de Valencia, University of Valencia, Valencia, Spain. · Hospital de Donostia, San Sebastián, Spain. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada. · Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain. · GEICAM (Spanish Breast Cancer Group), Madrid, Spain. · Complejo Hospitalario Universitario de Albacetee, Centro Regional de Investigaciones Biomédicas, Universidad de Castilla la Mancha, Albacete, Spain. · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Edificio de Investigación, Calle Francisco Javier de Moya, 02006, Albacete, Spain. · Pubmed 29766456
  • Translational Oncology Laboratory, Centro Regional de Investigaciones Biomédicas (CRIB), Universidad de Castilla La Mancha (UCLM), C/Almansa 14, 02008, Albacete, Spain. · Translational Research Unit, University Hospital, Albacete, Spain. · Department of Neuroscience, Yale School of Medicine, New Haven, CT, USA. · Translational Oncology Laboratory, Centro Regional de Investigaciones Biomédicas (CRIB), Universidad de Castilla La Mancha (UCLM), C/Almansa 14, 02008, Albacete, Spain. · Pubmed 29330624
2017
  • Instituto de Biología Molecular y Celular del Cáncer, CSIC, Salamanca, Spain. · Vall d'Hebron Institut d'Oncologia (VHIO), Barcelona, Spain. · CIBERONC, Madrid, Spain. · Departamento de Bioquímica y Biología Molecular, UAB, Barcelona, Spain. · Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. · Unidad de Investigación Traslacional Hospital Universitario de Albacete, Albacete, Spain. · Instituto de Biología Molecular y Celular del Cáncer, CSIC, Salamanca, Spain. · Pubmed 28687619
  • Translational Research Unit, Albacete University Hospital and Centro Regional de Investigaciones Biomedicas (CRIB), Castilla La Mancha University, Albacete, Spain. · Yale Cancer Center, Yale University, New Haven, USA. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. · Semmelweis University 2nd Department of Pediatrics, Budapest, Hungary. · MTA TTK Lendület Cancer Biomarker Research Group, Budapest, Hungary. · Cancer Research Center and CIBERONC, CSIC-University of Salamanca, Salamanca, Spain. · Pubmed 28423514
2016
  • University of Manitoba and CancerCare Manitoba, Winnipeg, Manitoba, Canada. Electronic address: · Translational Research Unit, Albacete University Hospital, Albacete, Spain. Electronic address: · Pubmed 27693931
  • Department of Medical Oncology, Kantonsspital St. Gallen, St. Gallen, and Faculty of Medicine, University Basel, Switzerland. · Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Department of Oncology, Queen's University, Kingston, ON, Canada. · Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau and Universitat Autònoma de Barcelona, Barcelona, Spain. · Divisions of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada. · Department of Medical Oncology, Institute of Oncology, Ljubljana, Slovenia. · Centro de Investigación del Cáncer CIC-CSIC, Universidad de Salamanca, Salamanca, Spain. · Pubmed 27149669
  • Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Cancer Research Center, CSIC-University of Salamanca, Salamanca, Spain. · Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Pubmed 27256375
  • Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. University of Toronto, Toronto, Ontario, Canada. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. University of Toronto, Toronto, Ontario, Canada. · Pubmed 27197164
  • Translational Research Unit, Albacete University Hospital, Calle Francisco Javier de Moya, 02006, Albacete, Spain. · Translational Research Unit, Albacete University Hospital, Calle Francisco Javier de Moya, 02006, Albacete, Spain. · Department of Medical Oncology and Hematology, Kantonsspital St. Gallen, St. Gallen, Switzerland. · Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. · IBMCC, CSIC-University of Salamanca, Salamanca, Spain. · Pubmed 26897635
  • Instituto de Biología Molecular y Celular del Cáncer, CSIC-Universidad de Salamanca, Salamanca, Spain. · Servicio de Oncología Médica, Complejo Hospitalario Universitario de Albacete, and AECC Unit, Albcete, Spain. · Pubmed 26364598
2015
  • Instituto de Biología Molecular y Celular del Cáncer, CSIC-Universidad de Salamanca, Salamanca, Spain. · EntreChem SL, Oviedo, Spain. · Translational Research Unit, Complejo Hospitalario Universitario de Albacete, Albacete, Spain. · Pubmed 26439989
  • Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Cancer Research Center, CSIC-University of Salamanca, Salamanca, Spain. · The Donnelly Centre, University of Toronto, Toronto, Canada. · EntreChem SL, Oviedo, Spain. · Pubmed 26314846
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada; Department of Medicine, University of Toronto, Toronto, ON, Canada. · Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada. · Escuela de Enfermeria, Universidad de Salamanca, Salamanca, Spain. · Medical Oncology Department, Salamanca University Hospital, Salamanca, Spain. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada. · Servicio de Cardiología, Complejo Hospitalario de Salamanca, Salamanca, Spain. · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Pubmed 26161666
  • Department of Medical Oncology and Hematology, CancerCare Manitoba and University of Manitoba, Winnipeg, MB, R3E 0V9, Canada. Electronic address: · Medical Oncology Department, Albacete University Hospital and AECC Unit, Albacete, Spain. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Center and University of Toronto, Toronto, Canada. · Pubmed 26112664
  • Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. · Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada. · Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada. · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Pubmed 26076967
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada. · Medical Oncology, University Hospital, Albacete, Spain. · Department of Oncology, McMaster University, Hamilton, Canada. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada. Electronic address: · Pubmed 25728257
  • Albacete University Hospital, Albacete, Spain · Albacete University Hospital, Albacete, Spain. · Instituto de Biología Molecular y Celular del Cancer-Centro Superior de Investigaciones Científicas, Universidad de Salamanca, Salamanca, Spain. · Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada. · Pubmed 25753437
  • Translational Oncology Research Unit, Albacete University Hospital, Albacete 02006, Spain. Electronic address: · Department of Medical Oncology, Institute of Oncology, Ljubljana, Slovenia. · Divisions of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, ON, Canada. · Pubmed 25706463
2014
  • Affiliations of authors: Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada (FEV-B, AJT, PdG, ID-P, PLB, MA-M, IFT, AO, EA) · Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia (BS) · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain (AO). · Pubmed 24273215
  • Instituto de Biología Molecular y Celular del Cáncer. CSIC-IBSAL-Universidad de Salamanca. Spain. · Tragara Pharmaceuticals, Carlsbad, CA, USA. · Hospital Universitario de Albacete, and AECC Unit, Spain. · Pubmed 25350956
  • Divisions of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada. · Translational Oncology Unit, Albacete University Hospital, Albacete, Spain. · Department of Medical Oncology, Institute of Oncology Ljubljana, Slovenia. · IBMCC-CSIC, Universidad de Salamanca, Spain. · Translational Oncology Unit, Albacete University Hospital, Albacete, Spain. Electronic address: · Pubmed 25217796
  • Translational Cancer Research Unit, Albacete University Hospital, 02006 Albacete, Spain. · Pubmed 24779793
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Department of Medicine, University of Toronto, Toronto, Canada ; Ministry of Higher Education, Riyadh, Saudi Arabia. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Department of Medicine, University of Toronto, Toronto, Canada. · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Pubmed 24586311
2013
  • Translational Research Unit and Medical Oncology Department, Albacete University Hospital, Albacete, Spain. · Pubmed 23221996
University Health Network of Toronto
2015
  • Princess Margaret Cancer Center, University of Toronto, Toronto, Canada (AO, FVB, AT, IT, EA). · Princess Margaret Cancer Center, University of Toronto, Toronto, Canada (AO, FVB, AT, IT, EA). · Pubmed 26283612
2014
  • Affiliations of authors: Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada (FEV-B, AJT, PdG, ID-P, PLB, MA-M, IFT, AO, EA) · Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia (BS) · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain (AO). · Pubmed 24273215
  • Instituto de Biología Molecular y Celular del Cáncer, CSIC-Universidad de Salamanca, Salamanca, Spain. · Pathology Department, Hospital Clínico Universitario de Salamanca, Salamanca, Spain. · Servicio de Oncología Médica, Complejo Hospitalario Universitario de Albacete, and AECC Unit, Albacete, Spain. · 1] Servicio de Oncología Médica, Complejo Hospitalario Universitario de Albacete, and AECC Unit, Albacete, Spain [2] Division of Medical Oncology and Hematology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada. · Pubmed 23246963
2013
  • Division of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, ON, Canada. · Pubmed 22703833
2018
  • Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, Toronto, Canada; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia; Research Unit, Albacete University Hospital, Albacete, Spain; Translational Oncology Laboratory, Regional Center for Biomedical Research, Castilla La Mancha University, Albacete, Spain. · Pubmed 28922781
2014
  • Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, 610 University Avenue, Toronto, ON, M5G 2M9, Canada, · Pubmed 24928527
2013
  • Division of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Canada. · Pubmed 23764179
  • Division of Medical Oncology & Hematology, Princess Margaret Hospital and University of Toronto, Toronto, Canada. · Pubmed 23303339
2012
  • Division of Medical Oncology and Hematology, Princess Margaret Hospital, 610 University Ave 5-124, Toronto, ON M5G 2M9, Canada. · Pubmed 22988040
  • Division of Medical Oncology and Hematology, Princess Margaret Hospital, Department of Medicine, University of Toronto, 610 University Avenue, Toronto, Ontario, Canada. · Pubmed 22956007
  • Mount Sinai Hospital and Princess Margaret Hospital, Toronto, ON, Canada. · Pubmed 22562122
2011
  • Division of Medical Oncology and Hematology, Princess Margaret Hospital, 610 University Ave, Toronto, ON M5G 2M9, Canada. · Pubmed 21743022
University of Toronto
2015
  • Princess Margaret Cancer Center, University of Toronto, Toronto, Canada (AO, FVB, AT, IT, EA). · Princess Margaret Cancer Center, University of Toronto, Toronto, Canada (AO, FVB, AT, IT, EA). · Pubmed 26283612
2014
  • Affiliations of authors: Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada (FEV-B, AJT, PdG, ID-P, PLB, MA-M, IFT, AO, EA) · Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia (BS) · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain (AO). · Pubmed 24273215
  • Instituto de Biología Molecular y Celular del Cáncer, CSIC-Universidad de Salamanca, Salamanca, Spain. · Pathology Department, Hospital Clínico Universitario de Salamanca, Salamanca, Spain. · Servicio de Oncología Médica, Complejo Hospitalario Universitario de Albacete, and AECC Unit, Albacete, Spain. · 1] Servicio de Oncología Médica, Complejo Hospitalario Universitario de Albacete, and AECC Unit, Albacete, Spain [2] Division of Medical Oncology and Hematology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada. · Pubmed 23246963
2018
  • Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, Toronto, Canada; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia; Research Unit, Albacete University Hospital, Albacete, Spain; Translational Oncology Laboratory, Regional Center for Biomedical Research, Castilla La Mancha University, Albacete, Spain. · Pubmed 28922781
2013
  • Division of Medical Oncology & Hematology, Princess Margaret Hospital and University of Toronto, Toronto, Canada. · Pubmed 23303339
2012
  • Division of Medical Oncology and Hematology, Princess Margaret Hospital, Department of Medicine, University of Toronto, 610 University Avenue, Toronto, Ontario, Canada. · Pubmed 22956007
6 Other Locations Show
Yearly article counts 19869854210
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.